Literature DB >> 21628309

Serum β2 microglobulin correlates with the new ESSDAI in patients with Sjögren's syndrome.

Marja Pertovaara, Markku Korpela.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21628309     DOI： 10.1136/ard.2011.153098

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

1.  Serological lymphocytic activity and patient-reported outcomes in Sjögren's syndrome.

Authors:  Maike Jülich; Anna-Maria Kanne; Bettina Sehnert; Stephan Budweiser; Reinhard E Voll; Florian Kollert
Journal:  Clin Rheumatol       Date:  2018-06-01       Impact factor: 2.980

2.  Recommendations for evaluation and diagnosis of extra-glandular manifestations of primary sjogren syndrome: results of an epidemiologic systematic review/meta-analysis and a consensus guideline from the Brazilian Society of Rheumatology (articular, pulmonary and renal).

Authors:  Virginia Fernandes Moça Trevisani; Alisson Pugliesi; Sandra Gofinet Pasoto; Maria Lucia Lemos Lopes; Lissiane Karine Noronha Guedes; Samira Tatiyama Miyamoto; Marilena Leal Mesquita Silvestre Fernandes; Sonia Cristina de Magalhães Souza Fialho; Aysa César Pinheiro; Laura Caldas Dos Santos; Simone Appenzeller; Tania Fidelix; Sandra Lúcia Euzébio Ribeiro; Danielle Christinne Soares Egypto de Brito; Tatiana Nayara Libório-Kimura; Maria Carmen Lopes Ferreira Silva Santos; Diego Ustárroz Cantali; Juliana D'Agostino Gennari; Vinicius Tassoni Civile; Ana Carolina Pereira Nunes Pinto; César Ramos Rocha-Filho; Fabiola Reis Oliveira; Aline Pereira da Rocha; Valeria Valim
Journal:  Adv Rheumatol       Date:  2022-06-01

3.  Clinical and laboratory evaluation of sicca complaints: distinctive aspects of primary, secondary and non-Sjogren syndrome.

Authors:  Fabíola Reis de Oliveira; Ana Carolina F Motta; Carolina Maria Módulo; Denny Marcos Garcia; John A Chiorini; Paulo Louzada-Junior; Eduardo Melani Rocha
Journal:  Adv Rheumatol       Date:  2022-07-01

Review 4.  Current and future therapies for primary Sjögren syndrome.

Authors:  Raphaèle Seror; Gaetane Nocturne; Xavier Mariette
Journal:  Nat Rev Rheumatol       Date:  2021-06-29       Impact factor: 20.543

5.  Persistent serological activity in primary Sjögren's syndrome.

Authors:  Jorge López-Morales; Daniel Cortes-Muñoz; Miguel Astudillo-Ángel; Gabriela Hernández-Molina
Journal:  Clin Rheumatol       Date:  2019-12-14       Impact factor: 2.980

6.  Serum 25-Hydroxyvitamin D3 and BAFF Levels Are Associated with Disease Activity in Primary Sjogren's Syndrome.

Authors:  Sang Jin Lee; Hye Jin Oh; Byoong Yong Choi; Yu Jin Jang; Joo Youn Lee; Jin Kyun Park; Yeong Wook Song
Journal:  J Immunol Res       Date:  2016-12-15       Impact factor: 4.818

7.  Salivary gland ultrasonography as a predictor of clinical activity in Sjögren's syndrome.

Authors:  Tania Fidelix; Adriano Czapkowski; Sergio Azjen; Adagmar Andriolo; Virginia F M Trevisani
Journal:  PLoS One       Date:  2017-08-04       Impact factor: 3.240

8.  Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort.

Authors:  Jacques-Eric Gottenberg; Raphaèle Seror; Corinne Miceli-Richard; Joelle Benessiano; Valerie Devauchelle-Pensec; Philippe Dieude; Jean-Jacques Dubost; Anne-Laure Fauchais; Vincent Goeb; Eric Hachulla; Pierre Yves Hatron; Claire Larroche; Véronique Le Guern; Jacques Morel; Aleth Perdriger; Xavier Puéchal; Stephanie Rist; Alain Saraux; Damien Sene; Jean Sibilia; Olivier Vittecoq; Gaétane Nocturne; Philippe Ravaud; Xavier Mariette
Journal:  PLoS One       Date:  2013-05-24       Impact factor: 3.240

Review 9.  EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide.

Authors:  Raphaèle Seror; Simon J Bowman; Pilar Brito-Zeron; Elke Theander; Hendrika Bootsma; Athanasios Tzioufas; Jacques-Eric Gottenberg; Manel Ramos-Casals; Thomas Dörner; Philippe Ravaud; Claudio Vitali; Xavier Mariette; Karsten Asmussen; Soren Jacobsen; Elena Bartoloni; Roberto Gerli; Johannes Wj Bijlsma; Aike A Kruize; Stefano Bombardieri; Arthur Bookman; Cees Kallenberg; Petra Meiners; Johan G Brun; Roland Jonsson; Roberto Caporali; Steven Carsons; Salvatore De Vita; Nicoletta Del Papa; Valerie Devauchelle; Alain Saraux; Anne-Laure Fauchais; Jean Sibilia; Eric Hachulla; Gabor Illei; David Isenberg; Adrian Jones; Menelaos Manoussakis; Thomas Mandl; Lennart Jacobsson; Frederic Demoulins; Carlomaurizio Montecucco; Wan-Fai Ng; Sumusu Nishiyama; Roald Omdal; Ann Parke; Sonja Praprotnik; Matjia Tomsic; Elizabeth Price; Hal Scofield; Kathy L Sivils; Josef Smolen; Roser Solans Laqué; Serge Steinfeld; Nurhan Sutcliffe; Takayuki Sumida; Guido Valesini; Valeria Valim; Frederick B Vivino; Cristina Vollenweider
Journal:  RMD Open       Date:  2015-02-20

10.  B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome.

Authors:  Katherine James; Chimwemwe Chipeta; Antony Parker; Stephen Harding; Simon J Cockell; Colin S Gillespie; Jennifer Hallinan; Francesca Barone; Simon J Bowman; Wan-Fai Ng; Benjamin A Fisher
Journal:  Rheumatology (Oxford)       Date:  2018-07-01       Impact factor: 7.580
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.